4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-21-003295
Chief Financial Officer sold 13,038 shares at an average $81.02 ($1,056,310)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Myszkowski Kenneth Allen Chief Financial Officer | 2021-01-11 | Sale | −11,597 | $81.02 | $939,589 | 445,446 | D |
| Myszkowski Kenneth Allen Chief Financial Officer | 2021-01-12 | Sale | −1,441 | $81.00 | $116,721 | 444,005 | D |
| Open-market sales · 13,038 sh · avg $81.02 · $1,056,310 | |||||||
Loading xslF345X03/doc4.xml…